Altox

Database / API & reference standards

API & reference standards

Cisapride

Cisapride is listed in the API and reference-standard collection. Its represented structure has formula C23H29ClFN3O4 and a calculated molecular weight of 465.95 g/mol.

2D chemical structure

O H 2 N C l O N H N O F O ( R ) ( S )

Chemical identity

Catalog name
Cisapride
Common name
Cisapride
Chemical name
4-amino-5-chloro-N-[(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-methoxybenzamide
CAS
Not available
SMILES
COc1cc(N)c(Cl)cc1C(=O)N[C@@H]1CCN(CCCOc2ccc(F)cc2)C[C@@H]1OC
InChI
InChI=1S/C23H29ClFN3O4/c1-30-21-13-19(26)18(24)12-17(21)23(29)27-20-8-10-28(14-22(20)31-2)9-3-11-32-16-6-4-15(25)5-7-16/h4-7,12-13,20,22H,3,8-11,14,26H2,1-2H3,(H,27,29)/t20-,22+/m1/s1
InChIKey
DCSUBABJRXZOMT-IRLDBZIGSA-N

Record ID: Afdb2ea9bdfd3

Computed properties

C23H29ClFN3O4 Molecular formula
465.953 g/molMolecular weight
465.1831 DaMonoisotopic exact mass
86.05 ŲTopological polar surface area
3.3581 Calculated LogP (Wildman–Crippen)
122.0366 cm³/molMolar refractivity (Wildman–Crippen)
6 countHydrogen-bond acceptors
2 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 3 6 9 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C Cl F H N O 0 8 16 24 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight465.95381.14
Calculated LogP (Wildman–Crippen)3.358168.38
Topological polar surface area86.0562.36
Hydrogen-bond acceptors675.83
Hydrogen-bond donors264.87
Rotatable bonds (strict)986.25

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC23H29ClFN3O4dimensionless
Molecular weight465.953g/mol
Monoisotopic exact mass465.1831Da
Topological polar surface area86.05Ų
Calculated LogP (Wildman–Crippen)3.3581dimensionless
Molar refractivity (Wildman–Crippen)122.0366cm³/mol
Hydrogen-bond acceptors6count
Hydrogen-bond donors2count
Rotatable bonds (strict)9count
Heavy atoms32count
Heteroatoms9count
Rings3count
Aromatic rings2count
Aliphatic rings1count
Saturated rings1count
Aromatic heterocycles0count
Aliphatic heterocycles1count
Saturated heterocycles1count
Aromatic carbocycles2count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.4348fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters2count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area192.1176Ų
Valence electrons174count
Radical electrons0count
Bertz complexity912.8597index
Balaban J1.4914index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Cisapride

PDE, HBEL and impurity assessment for Cisapride

For a substance-specific assessment, request a PDE report for Cisapride or explore HBEL derivation for Cisapride. These services address exposure limits using toxicological evidence and the intended use of the substance.

For pharmaceutical development, explore prediction of degradation products of Cisapride and qualification of impurities related to Cisapride.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Cisapride

Explore Altox services and software through the Altox Pharma-Hub.